Netherlands vs Norway: Treatment success rate for patients treated for MDR-TB
Netherlands
91.0%
in 2021
Norway
91.0%
in 2022
Netherlands rank
21st
Norway rank
21st
Treatment success rate for patients treated for MDR-TB over time
- Netherlands
- Norway
How they compare
Netherlands currently reports 91.0% against 91.0% in Norway, a difference of 0.0%.
The two have swapped places 9 times across 16 shared years of data; in 2003 it was Norway ahead.
Netherlands ranks 21st and Norway ranks 21st of 163 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.5% | 70.0% | 10.5% | Netherlands |
| 2010s | 77.0% | 74.4% | 2.6% | Netherlands |
| 2020s | 95.5% | 83.5% | 12.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Netherlands or Norway?
- Netherlands, at 91.0% against 91.0% in Norway as of 2021.
- What is the difference in treatment success rate for patients treated for mdr-tb between Netherlands and Norway?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Norway?
- 16 years are reported by both, from 2003 to 2021.
- How do Netherlands and Norway rank globally for treatment success rate for patients treated for mdr-tb?
- Netherlands ranks 21st and Norway ranks 21st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.